Increased expression of CCL2 is an indicator of the progression of human colorectal cancer while inhibiting CCL2 was reported to reduce the recruitment of MDSCs in colorectal cancer model (Chun et al., 2015). The gene discussed is CCL2; the disease is colorectal cancer.